Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...

The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...

The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled ...

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

Fine particles in the air can harm respiratory and cardiovascular health, making sensitive groups particularly vulnerable.

Iconovo AB (publ.), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that it has agreed to conduct a feasibility study on behal ...

THE Arctic blast bearing down on the UK could combine with a winter virus to form a “deadly duo” for millions with a common ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

Some people continue coughing after they recover from a common respiratory infection. Doctors explain why a cough can last ...

If the Welsh Life Sciences Investment Fund had kept its full stake in Verona for the long-term it could have been a huge ...

Meanwhile, NICE also published new guidance supporting NHS use of an AI-based automated tool, ArtiQ's ArtiQ.Spiro, which ...